Invention Grant
US07790859B2 Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors
有权
人抗IFN-γ中和抗体作为选择性IFN-γ途径抑制剂
- Patent Title: Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors
- Patent Title (中): 人抗IFN-γ中和抗体作为选择性IFN-γ途径抑制剂
-
Application No.: US11962594Application Date: 2007-12-21
-
Publication No.: US07790859B2Publication Date: 2010-09-07
- Inventor: Andrew A. Welcher , Hilary T. Chute , Yue-Sheng Li , Haichun Huang
- Applicant: Andrew A. Welcher , Hilary T. Chute , Yue-Sheng Li , Haichun Huang
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/46
Abstract:
This invention provides antibodies that interact with or bind to human interferon-gamma (IFN-γ) and methods for treating IFN-γ mediated diseases by administering a pharmaceutically effective amount of antibodies to IFN-γ. Methods of detecting the amount of IFN-γ in a sample using antibodies to IFN-γ are also provided.
Public/Granted literature
- US20080107655A1 HUMAN ANTI-IFN-GAMMA NEUTRALIZING ANTIBODIES AS SELECTIVE IFN-GAMMA PATHWAY INHIBITORS Public/Granted day:2008-05-08
Information query
